78 related articles for article (PubMed ID: 1121854)
1. [Evaluation of the preventive efficacy of bonaphthone in influenza].
Stel'makh SG
Vopr Virusol; 1975; (1):55-8. PubMed ID: 1121854
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and epidemiological aspects of influenza chemoprophylaxis with bonaphthone].
Zykov MP; Zlydnikov DM; Romanov IuA; Shvetsova EG; Malysheva AM
Vopr Virusol; 1975; (1):58-62. PubMed ID: 1092074
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the antiviral activity of rimantadine and bonafton].
Il'enko VI; Platonov VG; Khomenkova IK
Vopr Virusol; 1977; (2):223-8. PubMed ID: 898899
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effectiveness of bonafton and rimantadine in influenza].
Krylov VF; Alekseeva AA; Liarskaia TIa; Poliakova TG; Kupriashina LM
Vopr Virusol; 1976; (2):186-91. PubMed ID: 936578
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits].
Bogdanova NS; Nikolaeva IS; Pershin GN
Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924
[TBL] [Abstract][Full Text] [Related]
6. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
[TBL] [Abstract][Full Text] [Related]
7. [Experience in the use of Tebrophen for influenza prevention].
Stel'makh SG; Levchenko IF
Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):113-5. PubMed ID: 1098334
[TBL] [Abstract][Full Text] [Related]
8. Oral influenza vaccination with live attenuated viruses. 2. Protective efficacy during a type A(H3N2) epidemic.
Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
Boll Ist Sieroter Milan; 1975 Oct; 54(4):323-30. PubMed ID: 1203088
[TBL] [Abstract][Full Text] [Related]
9. [Protective action of remantadine during an influenza outbreak caused by virus A (H1N1) in December 1977].
Obrosova-Serova NP; Slepushkin AN; Kupriashina LM; Volkov VE; Pugaeva VP
Vopr Virusol; 1979; (4):353-7. PubMed ID: 483772
[TBL] [Abstract][Full Text] [Related]
10. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
11. [The protective action of arbidol during a rise in respiratory diseases in 1990].
Obrosova-Serova NP; Burtseva EI; Nevskiĭ IM; Karmanova RI; Nazarov VI; Pitkenen AA; Slepushkin AN
Vopr Virusol; 1991; 36(5):380-1. PubMed ID: 1666474
[TBL] [Abstract][Full Text] [Related]
12. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Carrat F; Duval X; Tubach F; Mosnier A; Van der Werf S; Tibi A; Blanchon T; Leport C; Flahault A; Mentré F;
Antivir Ther; 2012; 17(6):1085-90. PubMed ID: 22910171
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
[TBL] [Abstract][Full Text] [Related]
14. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility.
Bush KA; McAnulty J; McPhie K; Reynolds R; Boomer M; Clarkson LM; Quaine J; Dwyer DE;
Commun Dis Intell Q Rep; 2004; 28(3):396-400. PubMed ID: 15574064
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
[TBL] [Abstract][Full Text] [Related]
16. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
17. [Electron microscopic study of the antiviral action of bonafton in experimental influenza infection].
Stebaeva LF; Nikolaeva IS; Botkina EM; Pershin GN
Farmakol Toksikol; 1980; 43(6):708-14. PubMed ID: 7450010
[TBL] [Abstract][Full Text] [Related]
18. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
19. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
[TBL] [Abstract][Full Text] [Related]
20. Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak.
Rabinovich S; Baldini JT; Bannister R
Am J Med Sci; 1969 May; 257(5):328-35. PubMed ID: 4891873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
